Furthermore, Th17 cells and IL-17-mediated signaling are required for the development of experimental autoimmune diseases such as collagen-induced arthritis and experimental autoimmune encephalomyelitis, whereas regulatory T cells protect against experimental autoimmunity (11–15). Here, IL17A is linked to autoimmune disease.